Trial intelligence / Profile preview

Granisetron for Spinal-Induced Hypotension in Diabetic Parturients

NCT03091881Phase 4Completed

Sponsor
Suez Canal University
Start
Mar 2018
Primary completion
Sep 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in hypotension comparing Granisetron Group with Placebo Group (2 arms). Primary endpoint: Total Ephedrine consumption. Started Mar 2018; status: completed.

02

Drugs

granisetron
03

Conditions

hypotension

Beyond the preview

Go deeper on NCT03091881.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03091881.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call